Gentian Diagnostics ASA (OSL:GENT)
Norway
· Delayed Price · Currency is NOK 37.70
-1.30 (-3.33%)
Mar 9, 2026, 4:25 PM CET
Gentian Diagnostics ASA Revenue
In the year 2025, Gentian Diagnostics ASA had annual revenue of 176.50M NOK with 16.07% growth. Gentian Diagnostics ASA had revenue of 46.59M in the quarter ending December 31, 2025, with 9.35% growth.
Revenue
176.50M
Revenue Growth
+16.07%
P/S Ratio
3.29
Revenue / Employee
2.80M
Employees
63
Market Cap
581.42M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 176.50M | 24.43M | 16.07% |
| Dec 31, 2024 | 152.07M | 16.92M | 12.52% |
| Dec 31, 2023 | 135.15M | 23.23M | 20.76% |
| Dec 31, 2022 | 111.92M | 11.91M | 11.91% |
| Dec 31, 2021 | 100.01M | 21.13M | 26.78% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 699.77M |
| Nordhealth AS | 601.75M |
| Photocure ASA | 532.58M |
| Nykode Therapeutics AS | 4.57M |
| Vistin Pharma ASA | 452.29M |
| Omda AS | 495.69M |
| Lytix Biopharma AS | 377.00K |
| Circio Holding ASA | 123.00K |